Effects of Clioquinol Analogues on the Hypoxia-Inducible Factor Pathway and Intracelullar Mobilization of Metal Ions
- Authors
- Kim, So Yeon; Lee, Myong Jin; Kim, Jeong Won; Na, Yu-Ran; Lee, Ho-Youl; Cho, Hyunju; Lee, Keun Byeol; Lee, You Mie; Lee, Cheolju; Park, Hyunsung; Yang, Eun Gyeong
- Issue Date
- 2012-12
- Publisher
- PHARMACEUTICAL SOC JAPAN
- Citation
- BIOLOGICAL & PHARMACEUTICAL BULLETIN, v.35, no.12, pp.2160 - 2169
- Abstract
- We previously found that clioquinol (CQ) increases functional hypoxia-inducible factor-1 alpha (HIF-1 alpha) with enhanced transcription of its target genes. Here we report that compounds derived from 8-hydroxyquinoline including CQ, broxyquinoline (BQ), iodoquinol (IQ) and chloroacetoxyquinoline (CAQ) promote neovascularization effectively based on chick chorioallantoic membrane assays. The CQ analogues induce stabilization of H IF-1 alpha as well as enhance HIF-1-mediated vascular endothelial growth factor transcription. These analogues also exert inhibitory effects on the activity of prolyl and asparaginyl hydroxylations of H IF-1 alpha in vitro. Despite metal ion-dependent restoration of the inhibited HIF-1 alpha hydroxylase activity, the cellular HIF-1 alpha-inducing effects of the CQ analogues are reversed to varying degrees by Zn2+ and Fe2+. While CQ and BQ are completely reversed by Zn2+, co-administration of Zn2+ and IQ has only a partial reversing effect. On the other hand, CAQ-mediated stabilization of HIF-1 alpha is reversed by Fe2+ but not by Zn2+. These phenomena are found to coincide with elevation of the intracellular Zn2+ and Fe2+ levels by the CQ analogues, suggesting that metal ion effects on H IF-la in cells likely reflect the differential transporting capability of the analogues.
- Keywords
- PROLYL HYDROXYLASE INHIBITORS; UBIQUITIN-PROTEASOME PATHWAY; ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC TARGET; ALZHEIMERS-DISEASE; CANCER-THERAPY; FACTOR 1-ALPHA; FACTOR-I; ANGIOGENESIS; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; PROLYL HYDROXYLASE INHIBITORS; UBIQUITIN-PROTEASOME PATHWAY; ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC TARGET; ALZHEIMERS-DISEASE; CANCER-THERAPY; FACTOR 1-ALPHA; FACTOR-I; ANGIOGENESIS; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; 8-hydroxyquinoline derivative; hypoxia-inducible factor-1 alpha; zinc ion; prolyl hydroxylase domain 2; factor-inhibiting hypoxia-inducible factor-1; angiogenesis
- ISSN
- 0918-6158
- URI
- https://pubs.kist.re.kr/handle/201004/128615
- DOI
- 10.1248/bpb.b12-00507
- Appears in Collections:
- KIST Article > 2012
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.